BACKGROUND: Only few reports exist on @entity5 that require cardiopulmonary bypass during resection. We aimed to investigate the early and late clinical outcome of these @entity1 . METHODS: @entity1 with @entity5 that underwent surgery between 2002 and 2014 were analyzed. All @entity1 had cardiopulomonary bypass support during resection. Clinical and perioperative data was retrospectively reviewed for outcome and overall survival. RESULTS: Fifteen @entity1 (12 female, mean age of 55        15  years, range 24 to 80  years) were identified. Eleven (8 female) were diagnosed with primary @entity1514 and four with @entity3 . Three @entity1 died early postoperatively. @entity1 diagnosed with @entity242 had a significantly worse outcome than non- @entity242 @entity1 (83.3        15.2  % after 1  year, 31.3        24.5  % after 5  years vs. 83.3        15.2  % after 1  year, 0        0  % after 5  years, p   =   0.005). CONCLUSIONS: Malignancies with extension into cardiac structures or infiltration of great vessels can be resected with cardiopulmonary bypass support and tolerable risk. Carefully selected @entity1 can undergo advanced operative procedures with an acceptable 1-year-survival, but only few @entity1 achieved good long-term outcome.

Resection of XXXX infiltrating cardiac structures with use of cardiopulmonary bypass.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity242 :: ('MESH:D012509', 'Disease') :: ['sarcoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['malignant thoracic neoplasms', 'thoracic malignancies'] @entity1514 :: ('MESH:D013896', 'Disease') :: ['thoracic malignomas'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastases']
@entity5 :: (MESH:D009369,Disease) :: ['thoracic malignancies']
